{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:16:25Z","timestamp":1785536185379,"version":"3.56.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010731","name":"Faculty of Medicine, Chiang Mai University","doi-asserted-by":"publisher","award":["MED 046\/2017"],"award-info":[{"award-number":["MED 046\/2017"]}],"id":[{"id":"10.13039\/501100010731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiorenal syndrome (CRS), a serious condition with high morbidity and mortality, is characterized by the coexistence of cardiac abnormality and renal dysfunction. There is limited information about CRS in association thalassemia. This study aimed to investigate the prevalence of CRS in thalassemia patients and also associated risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thalassemia patients who attended the out-patient clinic of a tertiary care university hospital from October 2016 to September 2017 were enrolled onto this cross-sectional study. Clinical and laboratory findings from 2 consecutive visits, 3 months apart, were assessed. The criteria for diagnosis of CRS was based on a system proposed by Ronco and McCullough. Cardiac abnormalities are assessed by clinical presentation, establishment of acute or chronic heart failure using definitions from 2016 ESC guidelines or from structural abnormalities shown in an echocardiogram. Renal dysfunction was defined as chronic kidney disease according to the 2012 KDIGO guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 90 thalassemia patients, 25 (27.8%) had CRS. The multivariable analysis showed a significant association between CRS and extramedullary hematopoiesis (EMH) (odds ratio (OR) 20.55,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016); thalassemia type [\u03b2\n                      <jats:sup>0<\/jats:sup>\n                      \/\u03b2\n                      <jats:sup>E<\/jats:sup>\n                      vs \u03b2\n                      <jats:sup>0<\/jats:sup>\n                      \/\u03b2\n                      <jats:sup>0<\/jats:sup>\n                      thalassemia (OR 0.005,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002)]; pulmonary hypertension (OR 178.1,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001); elevated serum NT-proBNP (OR 1.028,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.022), and elevated 24-h urine magnesium (OR 1.913,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016). There was no association found between CRS and frequency of blood transfusion, serum ferritin, liver iron concentration, cardiac T2*, type of iron chelating agents, or urine neutrophil gelatinase-associated lipocalin level.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CRS is relatively common in thalassemia patients. Its occurrence is associated with laboratory parameters which are easily measured in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-020-01990-8","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T09:22:47Z","timestamp":1596446567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cardiorenal syndrome in thalassemia patients"],"prefix":"10.1186","volume":"21","author":[{"given":"Sorasak","family":"Makmettakul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2381-9292","authenticated-orcid":false,"given":"Adisak","family":"Tantiworawit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arintaya","family":"Phrommintikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pokpong","family":"Piriyakhuntorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanawat","family":"Rattanathammethee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasinee","family":"Hantrakool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chatree","family":"Chai-Adisaksopha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekarat","family":"Rattarittamrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalita","family":"Norasetthada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3790-4444","authenticated-orcid":false,"given":"Kanda","family":"Fanhchaksai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9123-9177","authenticated-orcid":false,"given":"Pimlak","family":"Charoenkwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suree","family":"Lekawanvijit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"key":"1990_CR1","first-page":"498","volume":"134","author":"S Fucharoen","year":"2011","unstructured":"Fucharoen S, Winichagoon P. Haemoglobinopathies in Southeast Asia. Indian J Med Res. 2011;134:498\u2013506.","journal-title":"Indian J Med Res"},{"issue":"2","key":"1990_CR2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/GIM.0b013e3181cd68ed","volume":"12","author":"A Cao","year":"2010","unstructured":"Cao A, Galanello R. Beta-thalassemia. Genet Med. 2010;12(2):61\u201376.","journal-title":"Genet Med"},{"key":"1990_CR3","first-page":"28","volume-title":"Guidelines for the clinical Management of Transfusion Dependent Thalassaemia (TDT)","author":"S Trompeter","year":"2008","unstructured":"Trompeter S, Cohen A. Blood transfusion. In: Cappellini MD, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A, editors. Guidelines for the clinical Management of Transfusion Dependent Thalassaemia (TDT). Nicosia: Thalassaemia International Federation; 2008. p. 28\u201341."},{"key":"1990_CR4","first-page":"1","volume-title":"Guidelines for the Management of non Transfusion Dependent Thalassaemia (NTDT)","author":"A Taher","year":"2013","unstructured":"Taher A, Vichinsky E, Musallam K, Cappellini MD, Viprakasit V. Introduction and blood transfusion. In: Weatherall D, editor. Guidelines for the Management of non Transfusion Dependent Thalassaemia (NTDT). Nicosia: Thalassaemia International Federation; 2013. p. 1\u201317."},{"key":"1990_CR5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/01.CIR.30.5.698","volume":"30","author":"MA Engle","year":"1964","unstructured":"Engle MA, Erlandson M, Smith CH. Late cardiac complications of chronic, severe, refractory Anemia with hemochromatosis. Circulation. 1964;30:698\u2013705.","journal-title":"Circulation"},{"key":"1990_CR6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/asheducation-2004.1.14","volume":"2004","author":"AR Cohen","year":"2004","unstructured":"Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E. Thalassemia. Hematology. 2004;2004:14\u201334.","journal-title":"Hematology"},{"key":"1990_CR7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1196\/annals.1345.006","volume":"1054","author":"C Borgna-Pignatti","year":"2005","unstructured":"Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, et al. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005;1054:40\u20137.","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"1990_CR8","first-page":"1187","volume":"89","author":"C Borgna-Pignatti","year":"2004","unstructured":"Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187\u201393.","journal-title":"Haematologica"},{"key":"1990_CR9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-10-42","volume":"10","author":"B Modell","year":"2008","unstructured":"Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:42.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"1990_CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/187152512799201172","volume":"10","author":"A Taksande","year":"2012","unstructured":"Taksande A, Prabhu S, Venkatesh S. Cardiovascular aspect of Beta-thalassaemia. Cardiovasc Hematol Agents Med Chem. 2012;10(1):25\u201330.","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"3","key":"1990_CR11","first-page":"497","volume":"22","author":"A Ahmadzadeh","year":"2011","unstructured":"Ahmadzadeh A, Jalali A, Assar S, Khalilian H, Zandian K, Pedram M. Renal tubular dysfunction in pediatric patients with beta-thalassemia major. Saudi J Kidney Dis Transpl. 2011;22(3):497\u2013500.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"8","key":"1990_CR12","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1681\/ASN.2011111070","volume":"23","author":"KM Musallam","year":"2012","unstructured":"Musallam KM, Taher AT. Mechanisms of renal disease in beta-thalassemia. J Am Soc Nephrol. 2012;23(8):1299\u2013302.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1990_CR13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000287238","volume":"123","author":"M Economou","year":"2010","unstructured":"Economou M, Printza N, Teli A, Tzimouli V, Tsatra I, Papachristou F, et al. Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox. Acta Haematol. 2010;123(3):148\u201352.","journal-title":"Acta Haematol"},{"issue":"1","key":"1990_CR14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2141.2010.08477.x","volume":"153","author":"CT Quinn","year":"2011","unstructured":"Quinn CT, Johnson VL, Kim HY, Trachtenberg F, Vogiatzi MG, Kwiatkowski JL, et al. Renal dysfunction in patients with thalassaemia. Br J Haematol. 2011;153(1):111\u20137.","journal-title":"Br J Haematol"},{"key":"1990_CR15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1824-7288-36-39","volume":"36","author":"EA Hamed","year":"2010","unstructured":"Hamed EA, ElMelegy NT. Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study. Ital J Pediatr. 2010;36:39.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"1990_CR16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/08998280.2007.11928230","volume":"20","author":"AJ Marengo-Rowe","year":"2007","unstructured":"Marengo-Rowe AJ. The thalassemias and related disorders. Proc (Bayl Univ Med Cent). 2007;20(1):27\u201331.","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"5","key":"1990_CR17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00277-019-03630-0","volume":"98","author":"J Chaloemwong","year":"2019","unstructured":"Chaloemwong J, Tantiworawit A, Rattanathammethee T, Chai-Adisaksopha C, Rattarittamrong E, Norasetthada L, et al. Hyperuricemia, urine uric excretion, and associated complications in thalassemia patients. Ann Hematol. 2019;98(5):1101\u201310.","journal-title":"Ann Hematol"},{"issue":"6","key":"1990_CR18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","volume":"31","author":"C Ronco","year":"2010","unstructured":"Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010;31(6):703\u201311.","journal-title":"Eur Heart J"},{"issue":"3","key":"1990_CR19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ajcn\/37.3.478","volume":"37","author":"SB Heymsfield","year":"1983","unstructured":"Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr. 1983;37(3):478\u201394.","journal-title":"Am J Clin Nutr"},{"key":"1990_CR20","first-page":"99","volume":"10","author":"PK Nielsen","year":"1994","unstructured":"Nielsen PK, Ladefoged J, Olgaard K. Lean body mass by dual energy X-ray absorptiometry (DEXA) and by urine and dialysate creatinine recovery in CAPD and pre-dialysis patients compared to normal subjects. Adv Perit Dial. 1994;10:99\u2013103.","journal-title":"Adv Perit Dial"},{"issue":"6","key":"1990_CR21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.clinbiochem.2009.12.008","volume":"43","author":"FC Grenier","year":"2010","unstructured":"Grenier FC, Ali S, Syed H, Workman R, Martens F, Liao M, et al. Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clin Biochem. 2010;43(6):615\u201320.","journal-title":"Clin Biochem"},{"issue":"8","key":"1990_CR22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891\u2013975.","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"1990_CR23","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2008.12.014","volume":"53","author":"PM Rautaharju","year":"2009","unstructured":"Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ, et al. AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009;53(11):982\u201391.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1990_CR24","doi-asserted-by":"crossref","first-page":"e18242","DOI":"10.5812\/ircmj.18242","volume":"17","author":"A Biharas Monfared","year":"2015","unstructured":"Biharas Monfared A, Agha Farajollah S, Sabour F, Farzanegan R, Taghdisi S. Comparison of radiological findings of chest x-ray with echocardiography in determination of the heart size. Iran Red Crescent Med J. 2015;17(1):e18242.","journal-title":"Iran Red Crescent Med J"},{"issue":"2","key":"1990_CR25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.ajkd.2014.10.013","volume":"65","author":"A Akbari","year":"2015","unstructured":"Akbari A, Clase CM, Acott P, Battistella M, Bello A, Feltmate P, et al. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management. Am J Kidney Dis. 2015;65(2):177\u2013205.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1990_CR26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/CIR.0b013e31829b2be6","volume":"128","author":"DJ Pennell","year":"2013","unstructured":"Pennell DJ, Udelson JE, Arai AE, Bozkurt B, Cohen AR, Galanello R, et al. Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association. Circulation. 2013;128(3):281\u2013308.","journal-title":"Circulation"},{"issue":"11","key":"1990_CR27","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1182\/blood.V97.11.3411","volume":"97","author":"A Aessopos","year":"2001","unstructured":"Aessopos A, Farmakis D, Karagiorga M, Voskaridou E, Loutradi A, Hatziliami A, et al. Cardiac involvement in thalassemia intermedia: a multicenter study. Blood. 2001;97(11):3411\u20136.","journal-title":"Blood"},{"issue":"3","key":"1990_CR28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1600-0609.2012.01819.x","volume":"89","author":"S Bhandari","year":"2012","unstructured":"Bhandari S, Galanello R. Renal aspects of thalassaemia a changing paradigm. Eur J Haematol. 2012;89(3):187\u201397.","journal-title":"Eur J Haematol"},{"issue":"9","key":"1990_CR29","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.amjmed.2005.02.021","volume":"118","author":"G Hahalis","year":"2005","unstructured":"Hahalis G, Alexopoulos D, Kremastinos DT, Zoumbos NC. Heart failure in beta-thalassemia syndromes: a decade of progress. Am J Med. 2005;118(9):957\u201367.","journal-title":"Am J Med"},{"issue":"3","key":"1990_CR30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCHEARTFAILURE.109.913863","volume":"3","author":"DT Kremastinos","year":"2010","unstructured":"Kremastinos DT, Farmakis D, Aessopos A, Hahalis G, Hamodraka E, Tsiapras D, et al. Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives. Circ Heart Fail. 2010;3(3):451\u20138.","journal-title":"Circ Heart Fail"},{"key":"1990_CR31","first-page":"135","volume":"4","author":"TS Garadah","year":"2010","unstructured":"Garadah TS, Mahdi N, Kassab S, Shoroqi IA, Abu-Taleb A, Jamsheer A. The pro-BNP serum level and echocardiographic tissue Doppler abnormalities in patients with Beta thalassemia major. Clin Med Insights Cardiol. 2010;4:135\u201341.","journal-title":"Clin Med Insights Cardiol"},{"issue":"1","key":"1990_CR32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ahj.2009.10.025","volume":"159","author":"DT Kremastinos","year":"2010","unstructured":"Kremastinos DT, Hamodraka E, Parissis J, Tsiapras D, Dima K, Maisel A. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major. Am Heart J. 2010;159(1):68\u201374.","journal-title":"Am Heart J"},{"issue":"4","key":"1990_CR33","first-page":"287","volume":"3","author":"D Ozyoruk","year":"2014","unstructured":"Ozyoruk D, Oner T, Oymak Y, Celik HT. Comparison of Doppler echocardiographic and tissue Doppler velocity data in beta-thalassaemia major with high and normal NT-proBNP levels of children in the south-east region of Turkey. Transl Pediatr. 2014;3(4):287\u201392.","journal-title":"Transl Pediatr"},{"issue":"5","key":"1990_CR34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ejheart.2006.11.004","volume":"9","author":"DT Kremastinos","year":"2007","unstructured":"Kremastinos DT, Tsiapras DP, Kostopoulou AG, Hamodraka ES, Chaidaroglou AS, Kapsali ED. NT-proBNP levels and diastolic dysfunction in beta-thalassaemia major patients. Eur J Heart Fail. 2007;9(5):531\u20136.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"1990_CR35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.blre.2010.08.004","volume":"24","author":"C Ponticelli","year":"2010","unstructured":"Ponticelli C, Musallam KM, Cianciulli P, Cappellini MD. Renal complications in transfusion-dependent beta thalassaemia. Blood Rev. 2010;24(6):239\u201344.","journal-title":"Blood Rev"},{"issue":"1","key":"1990_CR36","first-page":"1","volume":"4","author":"A Bakr","year":"2014","unstructured":"Bakr A, Al-Tonbary Y, Osman G, El-Ashry R. Renal complications of beta-thalassemia major in children. Am J Blood Res. 2014;4(1):1\u20136.","journal-title":"Am J Blood Res"},{"issue":"1","key":"1990_CR37","doi-asserted-by":"crossref","first-page":"e2014057","DOI":"10.4084\/mjhid.2014.057","volume":"6","author":"AA Tantawy","year":"2014","unstructured":"Tantawy AA, El Bablawy N, Adly AA, Ebeid FS. Early predictors of renal dysfunction in Egyptian patients with beta-thalassemia major and Intermedia. Mediterr J Hematol Infect Dis. 2014;6(1):e2014057.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"1","key":"1990_CR38","first-page":"16","volume":"5","author":"PA McCullough","year":"2004","unstructured":"McCullough PA, Kuncheria J, Mathur VS. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. Rev Cardiovasc Med. 2004;5(1):16\u201325.","journal-title":"Rev Cardiovasc Med"},{"issue":"11","key":"1990_CR39","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jacc.2018.01.056","volume":"71","author":"PA McCullough","year":"2018","unstructured":"McCullough PA, Kluger AY. Interpreting the wide range of NT-proBNP concentrations in clinical decision making. J Am Coll Cardiol. 2018;71(11):1201\u20133.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1990_CR40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.repc.2016.06.007","volume":"35","author":"AL Pinheiro da Silva","year":"2016","unstructured":"Pinheiro da Silva AL, Vaz da Silva MJ. Type 4 cardiorenal syndrome. Rev Port Cardiol. 2016;35(11):601\u201316.","journal-title":"Rev Port Cardiol"},{"issue":"8","key":"1990_CR41","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/ki.2011.198","volume":"80","author":"RG Fassett","year":"2011","unstructured":"Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE. Biomarkers in chronic kidney disease: a review. Kidney Int. 2011;80(8):806\u201321.","journal-title":"Kidney Int"},{"issue":"2","key":"1990_CR42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11897-011-0052-x","volume":"8","author":"M Comnick","year":"2011","unstructured":"Comnick M, Ishani A. Renal biomarkers of kidney injury in cardiorenal syndrome. Curr Heart Fail Rep. 2011;8(2):99\u2013105.","journal-title":"Curr Heart Fail Rep"},{"issue":"1","key":"1990_CR43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.kint.2016.09.003","volume":"91","author":"CY Hsu","year":"2017","unstructured":"Hsu CY, Xie D, Waikar SS, Bonventre JV, Zhang X, Sabbisetti V, et al. Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. Kidney Int. 2017;91(1):196\u2013203.","journal-title":"Kidney Int"},{"issue":"3","key":"1990_CR44","first-page":"307","volume":"69","author":"T Basturk","year":"2017","unstructured":"Basturk T, Sari O, Koc Y, Eren N, Isleem M, Kara E, et al. Prognostic significance of NGAL in early stage chronic kidney disease. Minerva Urol Nefrol. 2017;69(3):307\u201312.","journal-title":"Minerva Urol Nefrol"},{"issue":"2","key":"1990_CR45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2215\/CJN.03530708","volume":"4","author":"D Bolignano","year":"2009","unstructured":"Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(2):337\u201344.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"1990_CR46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/0971-4065.157799","volume":"26","author":"ML Patel","year":"2016","unstructured":"Patel ML, Sachan R, Verma A, Kamal R, Gupta KK. Neutrophil gelatinase-associated lipocalin as a biomarker of disease progression in patients with chronic kidney disease. Indian J Nephrol. 2016;26(2):125\u201330.","journal-title":"Indian J Nephrol"},{"key":"1990_CR47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/IJNRD.S87423","volume":"8","author":"ML Patel","year":"2015","unstructured":"Patel ML, Sachan R, Misra R, Kamal R, Shyam R, Sachan P. Prognostic significance of urinary NGAL in chronic kidney disease. Int J Nephrol Renovasc Dis. 2015;8:139\u201344.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"1","key":"1990_CR48","first-page":"73","volume":"53","author":"HY Lin","year":"2015","unstructured":"Lin HY, Hwang DY, Lee SC, Kuo HT, Kuo MC, Chang JM, et al. Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients. Clin Chem Lab Med. 2015;53(1):73\u201383.","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"1990_CR49","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2009.07.020","volume":"54","author":"M Haase","year":"2009","unstructured":"Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A. Group NM-aI. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;54(6):1012\u201324.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1990_CR50","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/cc13958","volume":"18","author":"R Matsa","year":"2014","unstructured":"Matsa R, Ashley E, Sharma V, Walden AP, Keating L. Plasma and urine neutrophil gelatinase-associated lipocalin in the diagnosis of new onset acute kidney injury in critically ill patients. Crit Care. 2014;18(4):R137.","journal-title":"Crit Care"},{"issue":"2","key":"1990_CR51","first-page":"72","volume":"31","author":"R Hawkins","year":"2011","unstructured":"Hawkins R. New biomarkers of acute kidney injury and the cardio-renal syndrome. Korean J Lab Med. 2011;31(2):72\u201380.","journal-title":"Korean J Lab Med"},{"issue":"5","key":"1990_CR52","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3109\/0886022X.2015.1033324","volume":"37","author":"C Soyler","year":"2015","unstructured":"Soyler C, Tanriover MD, Ascioglu S, Aksu NM, Arici M. Urine neutrophil gelatinase-associated lipocalin levels predict acute kidney injury in acute decompensated heart failure patients. Ren Fail. 2015;37(5):772\u20136.","journal-title":"Ren Fail"},{"issue":"1","key":"1990_CR53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5049\/EBP.2012.10.1.12","volume":"10","author":"SR Lee","year":"2012","unstructured":"Lee SR, Jeong KH. Novel biomarkers for cardio-renal syndrome. Electrolyte Blood Press. 2012;10(1):12\u20137.","journal-title":"Electrolyte Blood Press"},{"issue":"13","key":"1990_CR54","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jacc.2016.06.055","volume":"68","author":"AS Maisel","year":"2016","unstructured":"Maisel AS, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, et al. Neutrophil Gelatinase-associated Lipocalin for acute kidney injury during acute heart failure hospitalizations: the AKINESIS study. J Am Coll Cardiol. 2016;68(13):1420\u201331.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1990_CR55","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.cardfail.2019.05.009","volume":"25","author":"PT Murray","year":"2019","unstructured":"Murray PT, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, et al. Utility of urine neutrophil Gelatinase-associated Lipocalin for worsening renal function during hospitalization for acute heart failure: primary findings of the urine N-gal acute kidney injury N-gal evaluation of symptomatic heart failure study (AKINESIS). J Card Fail. 2019;25(8):654\u201365.","journal-title":"J Card Fail"},{"issue":"2","key":"1990_CR56","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ejhf.1642","volume":"22","author":"N Wettersten","year":"2020","unstructured":"Wettersten N, Horiuchi Y, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, et al. Short-term prognostic implications of serum and urine neutrophil gelatinase-associated lipocalin in acute heart failure: findings from the AKINESIS study. Eur J Heart Fail. 2020;22(2):251\u201363.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"1990_CR57","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/jch.12763","volume":"18","author":"KA John","year":"2016","unstructured":"John KA, Cogswell ME, Campbell NR, Nowson CA, Legetic B, Hennis AJ, et al. Accuracy and usefulness of select methods for assessing complete collection of 24-hour urine: a systematic review. J Clin Hypertens (Greenwich). 2016;18(5):456\u201367.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"11","key":"1990_CR58","first-page":"1192","volume":"81","author":"J Martensson","year":"2015","unstructured":"Martensson J, Glassford NJ, Jones S, Eastwood GM, Young H, Peck L, et al. Urinary neutrophil gelatinase-associated lipocalin to hepcidin ratio as a biomarker of acute kidney injury in intensive care unit patients. Minerva Anestesiol. 2015;81(11):1192\u2013200.","journal-title":"Minerva Anestesiol"},{"issue":"4","key":"1990_CR59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000360689","volume":"37","author":"C Ronco","year":"2014","unstructured":"Ronco C, Legrand M, Goldstein SL, Hur M, Tran N, Howell EC, et al. Neutrophil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective. Blood Purif. 2014;37(4):271\u201385.","journal-title":"Blood Purif"},{"key":"1990_CR60","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/DDDT.S79458","volume":"10","author":"CN Kontoghiorghe","year":"2016","unstructured":"Kontoghiorghe CN, Kontoghiorghes GJ. Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes. Drug Des Devel Ther. 2016;10:465\u201381.","journal-title":"Drug Des Devel Ther"},{"issue":"7","key":"1990_CR61","doi-asserted-by":"crossref","first-page":"e016028","DOI":"10.1136\/bmjopen-2017-016028","volume":"7","author":"KM Tecson","year":"2017","unstructured":"Tecson KM, Erhardtsen E, Eriksen PM, Gaber AO, Germain M, Golestaneh L, et al. Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study. BMJ Open. 2017;7(7):e016028.","journal-title":"BMJ Open"},{"issue":"2","key":"1990_CR62","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s10157-017-1483-9","volume":"22","author":"A Koratala","year":"2018","unstructured":"Koratala A. Renal functional reserve: time to find a new bottle for the old wine? Clin Exp Nephrol. 2018;22(2):486\u20137.","journal-title":"Clin Exp Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01990-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-01990-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01990-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T19:20:58Z","timestamp":1627932058000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01990-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1990"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01990-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-18146\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]},"assertion":[{"value":"4 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Subjects (or their parents or guardians) have given their written informed consent for their anonymized data to be included in this study.This study was approved by the ethical review board of the Faculty of Medicine, Chiang Mai University (STUDY CODE: MED-2559-043461 Research ID: 4346, Approval number 046\/2017).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"325"}}